Protect with SPF daily: Sun damage accelerates sagging and collagen breakdown
A meta-analysis of 45 clinical trials including 52,600 patients found no statistically significant increased risk of thyroid cancer in GLP-1 receptor agonist users
Coverage for GLP-1 medications under a POS plan will depend on whether your provider is in-network and whether prior authorization is required
The latest numbers from the World Health Organization (WHO) report that obesity affects Results of a phase 3 clinical trial recently published in The New England Journal of Medicine demonstrate Top-line results from this phase 3 clinical trial had originally been reported in April 2024 and found tirzepatide helps reduce symptom severity by almost two-thirds in adults with obesity and obstructive sleep apnea
In some cases, switching to a different medication with a different pharmacokinetic profile may be appropriate, as individual responses vary
But because the new drugs drastically reduce appetite, people taking them have the opposite problem: remembering to eat, and specifically making sure they consume enough protein to maintain muscle mass
